These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 34992486)
61. Seizure incidence among neuromyelitis optica spectrum disorder patients. Etemadifar M; Sabeti F; Khorvash R; Mirbagheri M; Nouri H; Salari M Rev Neurol (Paris); 2021 Jun; 177(6):655-659. PubMed ID: 33431266 [TBL] [Abstract][Full Text] [Related]
62. Eleven episodes of recurrent optic neuritis of the same eye for 22 years eventually diagnosed as neuromyelitis optica spectrum disorder. Yew YC; Hor JY; Lim TT; Kanesalingam R; Ching YM; Arip M; Easaw PE; Eow GB Mult Scler Relat Disord; 2016 Nov; 10():22-25. PubMed ID: 27919493 [TBL] [Abstract][Full Text] [Related]
63. Resolution of inflammation in neuromyelitis optica spectrum disorders. Wang X; Jiao W; Lin M; Lu C; Liu C; Wang Y; Ma D; Wang X; Yin P; Feng J; Zhu J; Zhu M Mult Scler Relat Disord; 2019 Jan; 27():34-41. PubMed ID: 30300851 [TBL] [Abstract][Full Text] [Related]
64. A comparative evaluation of different neuromyelitis optica spectrum disorder sets of criteria. Papeix C; Beigneux Y; Maillart E; de Seze J; Lubetzki C; Vukusic S; Collongues N; Marignier R Eur J Neurol; 2020 Nov; 27(11):2250-2256. PubMed ID: 32559008 [TBL] [Abstract][Full Text] [Related]
65. Non-invasive visual evoked potentials to assess optic nerve involvement in the dark agouti rat model of experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein. Castoldi V; Marenna S; d'Isa R; Huang SC; De Battista D; Chirizzi C; Chaabane L; Kumar D; Boschert U; Comi G; Leocani L Brain Pathol; 2020 Jan; 30(1):137-150. PubMed ID: 31267597 [TBL] [Abstract][Full Text] [Related]
66. Neuromyelitis Optica (Devic's Syndrome): an Appraisal. Crout TM; Parks LP; Majithia V Curr Rheumatol Rep; 2016 Aug; 18(8):54. PubMed ID: 27402111 [TBL] [Abstract][Full Text] [Related]
67. No association of Yang TT; He Y; Xiang YJ; Ao DH; Wang YY; Zhang Q; He XJ; Zhong SS; Wu J; Liu GZ Transl Neurosci; 2016; 7(1):76-83. PubMed ID: 28123825 [TBL] [Abstract][Full Text] [Related]
68. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients. Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690 [TBL] [Abstract][Full Text] [Related]
69. [From neuromyelitis optica to neuromyelitis optica spectrum disorder: from clinical syndrome to diagnistic classification]. Aktas O; Kümpfel T Nervenarzt; 2021 Apr; 92(4):307-316. PubMed ID: 33728474 [TBL] [Abstract][Full Text] [Related]
70. A Rare Presentation of Neuromyelitis Optica Spectrum Disorders. Singh NK; Sweidan AJ; Strube S; Carrillo-Nunez I Clin Med Insights Case Rep; 2018; 11():1179547617752685. PubMed ID: 29434480 [TBL] [Abstract][Full Text] [Related]
71. Distinguishing optic neuritis in neuromyelitis optica spectrum disease from multiple sclerosis: a novel magnetic resonance imaging scoring system. Storoni M; Davagnanam I; Radon M; Siddiqui A; Plant GT J Neuroophthalmol; 2013 Jun; 33(2):123-7. PubMed ID: 23609766 [TBL] [Abstract][Full Text] [Related]
72. Diagnostic procedures in suspected attacks in patients with neuromyelitis optica spectrum disorders: Results of an international survey. D'Souza M; Papadopoulou A; Levy M; Jacob A; Yeaman MR; Kümpfel T; Marignier R; Paul F; Brandt AU Mult Scler Relat Disord; 2020 Jun; 41():102027. PubMed ID: 32179483 [TBL] [Abstract][Full Text] [Related]
73. Treatment of neuromyelitis optica and neuromyelitis optica spectrum disorders with rituximab using a maintenance treatment regimen and close CD19 B cell monitoring. A six-year follow-up. Evangelopoulos ME; Andreadou E; Koutsis G; Koutoulidis V; Anagnostouli M; Katsika P; Evangelopoulos DS; Evdokimidis I; Kilidireas C J Neurol Sci; 2017 Jan; 372():92-96. PubMed ID: 28017256 [TBL] [Abstract][Full Text] [Related]
74. Characteristics of Visual Evoked Potential in Different Parts of Visual Impairment. Dai DK; Yang L; Meng HH; Chen XP; Tao LY Fa Yi Xue Za Zhi; 2021 Oct; 37(5):632-638. PubMed ID: 35187914 [TBL] [Abstract][Full Text] [Related]
75. Mechanisms for lesion localization in neuromyelitis optica spectrum disorders. Bradl M; Reindl M; Lassmann H Curr Opin Neurol; 2018 Jun; 31(3):325-333. PubMed ID: 29465432 [TBL] [Abstract][Full Text] [Related]
76. Central vein sign and other radiographic features distinguishing myelin oligodendrocyte glycoprotein antibody disease from multiple sclerosis and aquaporin-4 antibody-positive neuromyelitis optica. Ciotti JR; Eby NS; Brier MR; Wu GF; Chahin S; Cross AH; Naismith RT Mult Scler; 2022 Jan; 28(1):49-60. PubMed ID: 33870786 [TBL] [Abstract][Full Text] [Related]